Envista Holdings Debt Issuance/Retirement Net - Total 2018-2025 | NVST
Envista Holdings debt issuance/retirement net - total from 2018 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
| Envista Holdings Annual Debt Issuance/Retirement Net - Total (Millions of US $) |
|
|---|---|
| 2024 | $-100 |
| 2023 | $134 |
| 2022 | $0 |
| 2021 | $-476 |
| 2020 | $517 |
| 2019 | $1,318 |
| 2018 | $N/A |
| 2017 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.517B | $2.511B |
| Envista Holdings Corporation manufactures and sells dental products primarily in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics and dental eye loupes to oral surgeons, prosthodontists and periodontists; Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. Envista Holdings Corporation is based in Brea, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.924B | 25.68 |
| Boston Scientific (BSX) | United States | $159.425B | 38.08 |
| Stryker (SYK) | United States | $153.031B | 32.00 |
| EssilorLuxottica (ESLOY) | France | $136.054B | 0.00 |
| Medtronic (MDT) | Ireland | $118.007B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.909B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.800B | 25.00 |
| ResMed (RMD) | United States | $40.084B | 30.11 |
| GE HealthCare Technologies (GEHC) | United States | $35.372B | 16.79 |
| Agilent Technologies (A) | United States | $33.937B | 22.12 |
| Terumo (TRUMY) | Japan | $25.318B | 32.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.891B | 17.47 |
| Insulet (PODD) | United States | $20.174B | 79.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.257B | 12.37 |
| Baxter (BAX) | United States | $14.656B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.945B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.996B | 24.34 |
| Lantheus Holdings (LNTH) | United States | $5.072B | 12.79 |
| Perrigo (PRGO) | Ireland | $3.866B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.792B | 16.94 |
| Haemonetics (HAE) | United States | $3.582B | 16.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| LeMaitre Vascular (LMAT) | United States | $1.856B | 41.49 |
| QuidelOrtho (QDEL) | United States | $1.799B | 12.37 |
| AtriCure (ATRC) | United States | $1.526B | 0.00 |
| Acuren (TIC) | United States | $1.435B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.301B | 13.20 |
| Green Thumb Industries (GTBIF) | United States | $1.217B | 27.38 |
| Phibro Animal Health (PAHC) | United States | $1.208B | 15.44 |
| Neogen (NEOG) | United States | $1.098B | 14.06 |
| BioLife Solutions (BLFS) | United States | $1.074B | 0.00 |
| InMode (INMD) | Israel | $0.944B | 9.51 |
| Kestra Medical Technologies (KMTS) | United States | $0.859B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.838B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.741B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.667B | 0.00 |
| Owens & Minor (OMI) | United States | $0.637B | 5.28 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.569B | 0.00 |
| ZimVie (ZIMV) | United States | $0.523B | 23.77 |
| Surmodics (SRDX) | United States | $0.464B | 0.00 |
| SNDL (SNDL) | Canada | $0.420B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.317B | 11.65 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.312B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.298B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.274B | 81.33 |
| Viemed Healthcare (VMD) | United States | $0.255B | 21.53 |
| OraSure Technologies (OSUR) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.240B | 0.00 |
| Biote (BTMD) | United States | $0.232B | 6.52 |
| Brainsway (BWAY) | Israel | $0.225B | 59.45 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.39 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.156B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.65 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Jin Medical (ZJYL) | China | $0.110B | 0.00 |
| Safety Shot (SHOT) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 12.98 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Agape ATP (ATPC) | $0.074B | 0.00 | |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.21 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 50.43 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |